Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 602


Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study.

Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, Jouneau S, Postil D, Rogez S, Valette M, Merle C, Régis C, Costa Y, Lesieur Z, Tattevin P, Lina B, Carrat F, Launay O; FLUVAC Study Group.

J Clin Virol. 2016 Apr 12;79:68-73. doi: 10.1016/j.jcv.2016.04.005. [Epub ahead of print]


Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice.

García M, Misplon JA, Price GE, Lo CY, Epstein SL.

PLoS One. 2016 Apr 7;11(4):e0153195. doi: 10.1371/journal.pone.0153195. eCollection 2016.


Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio.

Strindhall J, Ernerudh J, Mörner A, Waalen K, Löfgren S, Matussek A, Bengner M.

Infect Dis (Lond). 2016 Jun;48(6):436-42. doi: 10.3109/23744235.2015.1135252. Epub 2016 Jan 25.


Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15.

Qin Y, Zhang Y, Wu P, Feng S, Zheng J, Yang P, Pan Y, Wang Q, Feng L, Pang X, Puig-Barberà J, Yu H, Cowling BJ.

Vaccine. 2016 Apr 29;34(20):2329-33. doi: 10.1016/j.vaccine.2016.03.068. Epub 2016 Mar 28.


Human influenza viruses and CD8(+) T cell responses.

Grant EJ, Quiñones-Parra SM, Clemens EB, Kedzierska K.

Curr Opin Virol. 2016 Feb;16:132-42. doi: 10.1016/j.coviro.2016.01.016. Epub 2016 Mar 12. Review.


Highly Predictive Model for a Protective Immune Response to the A(H1N1)pdm2009 Influenza Strain after Seasonal Vaccination.

Jürchott K, Schulz AR, Bozzetti C, Pohlmann D, Stervbo U, Warth S, Mälzer JN, Waldner J, Schweiger B, Olek S, Grützkau A, Babel N, Thiel A, Neumann AU.

PLoS One. 2016 Mar 8;11(3):e0150812. doi: 10.1371/journal.pone.0150812. eCollection 2016.


Safety, immunogenicity and cross-reactivity of a Northern hemisphere 2013-2014 seasonal trivalent inactivated split influenza virus vaccine, Anflu®.

Shen Y, Hu Y, Meng F, Du W, Li W, Song Y, Ji X, Huo L, Fu Z, Yin W.

Hum Vaccin Immunother. 2016 Mar 2:1-6. [Epub ahead of print]


CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice.

Ramirez A, Co M, Mathew A.

PLoS One. 2016 Mar 2;11(3):e0150425. doi: 10.1371/journal.pone.0150425. eCollection 2016.


Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.

Russell RF, McDonald JU, Lambert L, Tregoning JS.

J Virol. 2016 Apr 14;90(9):4735-44. doi: 10.1128/JVI.03159-15. Print 2016 May 1.


Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice.

Yam KK, Gupta J, Allen EK, Burt KR, Beaulieu É, Mallett CP, Burt DS, Ward BJ.

Vaccine. 2016 Mar 14;34(12):1444-51. doi: 10.1016/j.vaccine.2016.02.012. Epub 2016 Feb 9.


Selenium supplementation has beneficial and detrimental effects on immunity to influenza vaccine in older adults.

Ivory K, Prieto E, Spinks C, Armah CN, Goldson AJ, Dainty JR, Nicoletti C.

Clin Nutr. 2015 Dec 24. pii: S0261-5614(15)00340-4. doi: 10.1016/j.clnu.2015.12.003. [Epub ahead of print]


Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1.

Jiang J, Fisher EM, Concannon M, Lustigman S, Shen H, Murasko DM.

Vaccine. 2016 Feb 10;34(7):887-92. doi: 10.1016/j.vaccine.2016.01.003. Epub 2016 Jan 13.


Effect of mass media on influenza vaccine coverage in the season 2014/2015: a regional survey in Lazio, Italy.

Capanna A, Gervasi G, Ciabattini M, Volpe E, Spadea A, Sgricia S, Zaratti L, Franco E.

J Prev Med Hyg. 2015 Aug 5;56(2):E72-6.


Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.

Nachbagauer R, Choi A, Izikson R, Cox MM, Palese P, Krammer F.

MBio. 2016 Jan 19;7(1):e01996-15. doi: 10.1128/mBio.01996-15.


Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial.

Dunning AJ, DiazGranados CA, Voloshen T, Hu B, Landolfi VA, Talbot HK.

Clin Vaccine Immunol. 2016 Jan 13;23(3):228-35. doi: 10.1128/CVI.00604-15.


Effect of influenza vaccination on the prognosis of hospitalized influenza patients.

Casado I, Domínguez A, Toledo D, Chamorro J, Force L, Soldevila N, Astray J, Egurrola M, Godoy P, Mayoral JM, Tamames S, Sanz F, Castilla J, The Project Pi12/02079 Working Group.

Expert Rev Vaccines. 2016 Mar;15(3):425-432. Epub 2016 Jan 20.


Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.

Cowling BJ, Feng S, Finelli L, Steffens A, Fowlkes A.

Vaccine. 2016 Jan 2;34(1):61-6. doi: 10.1016/j.vaccine.2015.11.016. Epub 2015 Nov 21.


Partial Protection Induced by 2011-2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People.

Camilloni B, Basileo M, Menculini G, Tozzi P, Iorio AM.

Adv Exp Med Biol. 2016;897:45-53. doi: 10.1007/5584_2015_5003.


Vitamin D, Leptin and Impact on Immune Response to Seasonal Influenza A/H1N1 Vaccine in Older Persons.

Sadarangani SP, Ovsyannikova IG, Goergen K, Grill DE, Poland GA.

Hum Vaccin Immunother. 2015 Nov 17:0. [Epub ahead of print]


Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.

Hung IF, Zhang AJ, To KK, Chan JF, Li P, Wong TL, Zhang R, Chan TC, Chan BC, Wai HH, Chan LW, Fong HP, Hui RK, Kong KL, Leung AC, Ngan AH, Tsang LW, Yeung AP, Yiu GC, Yung W, Lau JY, Chen H, Chan KH, Yuen KY.

Lancet Infect Dis. 2016 Feb;16(2):209-18. doi: 10.1016/S1473-3099(15)00354-0. Epub 2015 Nov 9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk